Clinical update: COPD & Asthma – The main underlying problem with asthma is airways inflammation, which leads to asthma symptoms and reduced lung function. Inhaled steroids are generally the main initial therapy for many asthmatics. However, the first-line treatment for patients with milder disease would be a short-acting reliever (blue inhaler) for breakthrough symptoms. All [...]
Quitting is crucial in managing COPD
Clinical update: COPD & Asthma – A total of 85-90 per cent of people who develop chronic obstructive pulmonary disease (COPD) are smokers, the Asthma Society of Ireland reports. COPD is a growing problem and about 30 per cent of people who have the condition are smokers who continue to smoke, said Prof Richard Costello, [...]
Genetic mutation may predispose to asthma
Clinical update: COPD & Asthma – Mutations in the filaggrin gene among many Irish families predisposes them to develop eczema and this may progress later to asthma, revealed Prof Padraic Fallon, Science Foundation Ireland Stokes Professor of Translational Immunology at TCD’s Institute of Molecular Medicine. The absence of infections in developed societies – viral or [...]
Researchers study immune system’s role in triggering asthma
Clinical update: COPD & Asthma – There has been a confluence of two advances in asthma, said Dr Conor Burke, Respiratory Consultant at Connolly Hospital in Blanchardstown. There has been a confluence of two advances in asthma, said Dr Conor Burke, Respiratory Consultant at Connolly Hospital in Blanchardstown. To get asthma, you have to have [...]
Combineb
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport restricted -agonists. Active ingredients: Ipratropium bromide (as monohydrate) / salbutamol (as sulphate), 0.5mg/2.5mg per 2.5ml. Description: Colourless nebuliser solution in ampoule. Presentation: 2.5ml-60, €26.40. Indication: Management of bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD) who require regular treatment with both ipratropium bromide and [...]
Ipravent
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Ipratropium bromide 250µg/1ml. Description: Clear, colourless nebuliser solution. Presentation: 1ml-20, €4.08; 2ml-20, €4.85. Indications: Reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD). With concomitant inhaled β2-agonists, for treatment of reversible airways obstruction as in acute and chronic asthma. Pharmacology: Ipratropium bromide is [...]
New drug improves lung function in patients with COPD
A potential new treatment for COPD has been shown to significantly improve lung function A potential new breakthrough in the treatment of chronic obstructive pulmonary disease (COPD) that targets the underlying inflammation has been shown to significantly improve lung function and also reduce exacerbations in patients with COPD. Roflumilast also demonstrated additional benefits when added [...]
Can pharmacotherapy impact on disease progression in COPD?
Dr Anthony O’Regan takes a look at chronic obstructive pulmonary disorder and examines whether pharmacotherapy can have an effect on the progression of the disease. The sixth World COPD Day took place last month, on November 19. It is an annual event organis-ed by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) with the [...]
Sharing the care of COPD
Dr Finbarr O’Connell outlines the benefits of St James’s Hospital’s award-winning Respiratory Outreach Programme for the management of COPD in the community. Early discharge initiatives, initially set up six years ago for acute exacerbation of chronic obstructive pulmonary disease (COPD), have evolved into comprehensive chronic respiratory disease programmes, managing all aspects of COPD in the [...]
Spiriva Respimat
Prescription. GMS. Sport Permitted. Boehringer Ingelheim and Pfizer Healthcare are pleased to announce the introduction of Spiriva Respimat this month. The Respimat Soft Mist Inhaler is a new delivery device for Spiriva (tiotropium bromide). The Respimat Soft Mist Inhaler represents a new generation in inhaler design. It is a propellant free device, which uses the [...]